Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.
Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon Jv, Houben R, Dingemans AM, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, Oellers M, Lambin P, Bosmans G, Dekker AL, De Ruysscher D. Aerts HJ, et al. Among authors: wanders r. Radiother Oncol. 2009 Jun;91(3):386-92. doi: 10.1016/j.radonc.2009.03.006. Epub 2009 Mar 28. Radiother Oncol. 2009. PMID: 19329207 Free PMC article.
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study.
De Ruysscher D, Botterweck A, Dirx M, Pijls-Johannesma M, Wanders R, Hochstenbag M, Dingemans AM, Bootsma G, Geraedts W, Simons J, Pitz C, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Ann Oncol. 2009 Jan;20(1):98-102. doi: 10.1093/annonc/mdn559. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718891 Free article.
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: wanders r. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
De Ruysscher D, Wanders R, van Haren E, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. doi: 10.1016/j.ijrobp.2007.09.048. Epub 2007 Nov 26. Int J Radiat Oncol Biol Phys. 2008. PMID: 18037581 Clinical Trial.
Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: wanders r. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1103-10. doi: 10.1016/j.ijrobp.2007.11.028. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258382 Clinical Trial.
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
van Loon J, Offermann C, Bosmans G, Wanders R, Dekker A, Borger J, Oellers M, Dingemans AM, van Baardwijk A, Teule J, Snoep G, Hochstenbag M, Houben R, Lambin P, De Ruysscher D. van Loon J, et al. Among authors: wanders r. Radiother Oncol. 2008 Apr;87(1):49-54. doi: 10.1016/j.radonc.2008.02.019. Epub 2008 Mar 14. Radiother Oncol. 2008. PMID: 18342967
Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.
De Ruysscher D, Dehing C, Yu S, Wanders R, Ollers M, Dingemans AM, Bootsma G, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Radiother Oncol. 2009 Jun;91(3):353-9. doi: 10.1016/j.radonc.2008.10.006. Epub 2008 Nov 13. Radiother Oncol. 2009. PMID: 19012981
Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.
van Loon J, Grutters J, Wanders R, Boersma L, Oellers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Fatah SA, Snoep G, Hochstenbag M, Lambin P, De Ruysscher D. van Loon J, et al. Among authors: wanders r. Eur J Cancer. 2009 Mar;45(4):588-95. doi: 10.1016/j.ejca.2008.10.017. Epub 2008 Dec 4. Eur J Cancer. 2009. PMID: 19046631
1,110 results